Mumbai, often hailed as the financial capital of India, stands as the critical gateway for the global Active Pharmaceutical Ingredients (API) and Intermediates trade. With its proximity to the Jawaharlal Nehru Port Trust (JNPT), Mumbai handles over 50% of India's containerized cargo, making it the most vital logistics hub for pharmaceutical raw materials entering the Asian sub-continent.
Our service focus in Mumbai extends beyond simple supply; we integrate with the local Maharashtra Industrial Development Corporation (MIDC) corridors—stretching from Thane and Belapur to Taloja and Patalganga. These clusters house thousands of formulation units that rely on consistent, high-purity APIs and high-value intermediates to maintain their export-quality standards for the USFDA and EMA markets.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts. Our commitment to Mumbai's industry is built on a foundation of E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness). We understand the stringent regulatory requirements of the Indian Pharmacopoeia (IP) and the complexities of international trade compliance.
Revolutionizing API Synthesis through Advanced Chemical Engineering
Serum Pharma continuously monitors cutting-edge markets. We offer customization of Pre-Mix services to streamline Mumbai's formulation processes, reducing manufacturing complexity and enhancing bio-availability.
Improving the stability and solubility of poorly water-soluble APIs. Our co-crystallization technology provides a competitive edge for Indian pharmaceutical giants aiming for the "Generic Plus" market.
The future of green chemistry. We utilize advanced bio-fermentation to produce high-purity intermediates, reducing the environmental footprint—a key priority for Mumbai's sustainable industrial growth.
The global pharmaceutical landscape is currently witnessing a tectonic shift with the emergence of oral small-molecule GLP-1 receptor agonists. As highlighted in our recent market analysis, Eli Lilly's Foundayo™ (orforglipron) has set a record for the fastest FDA approval. This breakthrough signifies a move away from peptide-based injectables toward more accessible oral treatments.
For Mumbai's pharmaceutical exporters, this represents a massive opportunity in the API Intermediate sector. We provide the critical chemical building blocks required for these next-generation weight-loss and diabetes treatments. By bridging the gap between China’s massive synthesis capacity and Mumbai’s formulation expertise, we create a resilient supply chain that can withstand global volatility.
Application of Water-Soluble Pea Peptides and MCT Powders in Mumbai-based health supplement brands (Vile Parle & Andheri East clusters).
Integration of Dexamethasone Sodium Phosphate API into essential medicines distributed through Mumbai’s vast healthcare network.
Supplying Plant-derived Squalene and Essential Oils (Eucalyptus, Cinnamon) to luxury personal care manufacturers in the Mumbai Metropolitan Region (MMR).
For standard APIs and intermediates, the sea freight transit time from China to Mumbai (JNPT) is approximately 14-18 days. We also offer air freight to Mumbai International Airport (BOM) for urgent requirements, taking 3-5 days.
Yes, all our pharmaceutical-grade products are manufactured in WHO-GMP certified facilities and can be tailored to meet IP, BP, USP, or EP standards depending on your formulation needs.
We provide comprehensive documentation support, including COA, MSDS, and for key APIs, we offer support with DMF filings to assist our Mumbai partners in their global export registrations.
Connect with our expert team for regulatory-compliant APIs and specialized nutritional intermediates.
Get a Quote Today
